✦ LIBER ✦

PDB23 ECONOMIC EVALUATION OF DETEMIR-BASED BASAL/BOLUS THERAPY VERSUS NPH-BASED BASAL/BOLUS THERAPY FOR TYPE-1 DIABETES IN GERMANY

✍ Scribed by AJ Palmer; WJ Valentine; KU Wittrup-Jensen; S Roze

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB14 ECONOMIC EVALUATION OF DETEMIR-BAS

✍ S Roze; K Wittrup-Jensen; WJ Valentine; AJ Palmer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Cost-effectiveness of detemir-based basa

✍ Palmer, Andrew J.; Roze, Stéphane; Valentine, William J.; Smith, Inger; Wittrup- 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 361 KB

PDB21 COST-EFFECTIVENESS ANALYSIS OF BAS

✍ WJ Valentine; KU Wittrup-Jensen; AJ Palmer; S Roze 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PDB25 COST-EFFECTIVENESS OF DETEMIR VERS

✍ H Scheijbeler; M Aagren; S Nielsen; G Goodall; R Kotchie; WJ Valentine 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PDB28 COST-EFFECTIVENESS ANALYSES OF BAS

✍ WJ Valentine; AJ Palmer; KU Wittrup-Jensen; S Roze 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Insulin analogues (insulin detemir and i

✍ K. Hermansen; P. Fontaine; K. K. Kukolja; V. Peterkova; G. Leth; M.-A. Gall 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 286 KB